2016
DOI: 10.1016/j.transci.2016.07.019
|View full text |Cite
|
Sign up to set email alerts
|

Safety and efficacy of the leukocytapheresis procedure in eighty-five patients with rheumatoid arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 30 publications
(70 reference statements)
1
3
0
Order By: Relevance
“…In our cases, the numbers of leukocytes in peripheral circulation decreased after the completion of each LCAP session, yet by the next session, these numbers had recovered. A similar phenomenon has been observed in previous reports [3,6]. Hidaka et al have reported that during the recovery of peripheral leukocytes, activated T lymphocytes, which are well known to play a critical role in RA pathogenesis, are redistributed from the affected joints into the circulating blood.…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…In our cases, the numbers of leukocytes in peripheral circulation decreased after the completion of each LCAP session, yet by the next session, these numbers had recovered. A similar phenomenon has been observed in previous reports [3,6]. Hidaka et al have reported that during the recovery of peripheral leukocytes, activated T lymphocytes, which are well known to play a critical role in RA pathogenesis, are redistributed from the affected joints into the circulating blood.…”
Section: Discussionsupporting
confidence: 87%
“…Previous studies have shown the therapeutic effectiveness and safety of LCAP for the treatment of RA patients who are refractory to multiple csDMARDs [4][5][6]. Although comparable data regarding bDMARD-resistant patients is limited, there are a few published cases, in which high-throughput LCAP restored a reduced response to infliximab in RA patients [7].…”
Section: Discussionmentioning
confidence: 99%
“…Several groups have tested this therapy to dozens of patients with active RA and observed improvement of articular symptoms. [100][101][102] However, no groups attributed the improvement to the decrease in circulating neutrophils. To decrease circulating neutrophils, anti-IL-17A antibody would also be effective because IL-17A stimulates bone marrow stroma cells to secrete G-CSF.…”
Section: Suppression Of Neutrophil Recruitment May Be a Promising The...mentioning
confidence: 99%
“…Rheumatoid arthritis (RA) is a systemic inflammatory disease in which the predominant symptom is polyarthritis characterized by destructive synovitis and various immune disorders [1,2]. Synovial inflammation promotes an immune response that causes articular cartilage degradation leading to joint space narrowing (JSN) [3,4].…”
Section: Introductionmentioning
confidence: 99%